- $22.63bn
- $24.06bn
- $5.94bn
Annual income statement for Steris, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
R2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4,223 | 4,536 | 5,139 | 5,460 | 5,936 |
| Cost of Revenue | |||||
| Gross Profit | 1,883 | 1,981 | 2,218 | 2,403 | 2,627 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3,746 | 3,745 | 4,303 | 4,585 | 4,838 |
| Operating Profit | 478 | 791 | 836 | 874 | 1,098 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 367 | 680 | 703 | 796 | 1,047 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 284 | 556 | 553 | 612 | 785 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 244 | 107 | 378 | 615 | 782 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 244 | 107 | 378 | 615 | 782 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 4.91 | 5.85 | 6.2 | 7.09 | 8.07 |
| Dividends per Share |